The long awaited second phase in the Australian Competition and Consumer Commission’s cartel proceedings against Air New Zealand has been set down for June 27, one year after the High Court ruled the airline had breached Australia’s competition law.
AMP’s chairwoman Catherine Brennar has resigned and the firm’s general counsel has left, as the company faces possible criminal charges for misleading the corporate regulator over its decade-long practice of charging undue fees to clients.
Cargill has won a discovery dispute in a case alleging fraudulent concealment by Viterra in its $420 million sale of malt producer Joe White Maltings to Cargill Australia in 2013, with a judge finding documents attached to privileged emails or emails that are part of a privileged chain are protected by legal professional privilege.
AMP’s chief executive Craig Meller has resigned after this week’s shocking revelations that the company misled ASIC over fees charged to customers and may have influenced a Clayton Utz report to the securities regulator.
A lawyer for the University of Sydney has attacked ObjectiVision for failing to produce any commercial benefits from the glaucoma detection method at the centre of a patent infringement dispute, despite holding exclusive rights to the technology for 11 years.
Expert witnesses were pitted against each other Wednesday at a trial alleging generic makers infringed a patent covering the anti-depressant Lexapro, and Apotex’ consultant took the brunt of it.
The maker of the anti-depressant Lexapro faced off Monday against Apotex, Aspen Pharma and Sandoz at a court hearing over the rights to make generic versions of the top-selling product, with a barrister for Lundbeck slamming the three companies’ defence that their drugs were different.
In a long-running intellectual property fight with the University of Sydney, an expert witness for ophthalmic diagnostic device maker ObjectiVision has been grilled in the witness box over a report that claims parts of the company’s AccuMap system was copied.
Australian biotech company Holista Colltech has resolved litigation over ASX announcements that said it was collaborating with a Nobel Prize nominee to file a patent for the world’s first low-GI sugar.
Reckitt Benckiser Australia has lost a bid for an interim ban on a commercial by rival Procter & Gamble that claims Fairy Platinum dishwashing detergent is better than RBA’s Finish Quantum detergent, with a judge ruling the scientific evidence backs up the claim.